OUR STRATEGY

Performance against Strategy

OUR STRATEGY

Performance against Strategy

TESTING AND QUALITY

Aspiration

  • Provide quality testing in an efficient manner

Strategic Priorities

  • Harmonise quality standards to meet international benchmarks
  • SANBS products and services meet the quality control requirements at regulatory bodies and national standards to meet internal and external customer requirements

FY22 Highlights

  • Blood safety index maintained consistently above target
  • 100% SANAS Accreditation maintained

Contribution to Long-term Sustainable Value

Related Material
Matters

  • Regulatory landscape
  • Future changing world
  • Financial and organisational sustainability

TESTING AND QUALITY

Aspiration

  • Provide quality testing in an efficient manner

Strategic Priorities

  • Harmonise quality standards to meet international benchmarks
  • SANBS products and services meet the quality control requirements at regulatory bodies and national standards to meet internal and external customer requirements

FY22 Highlights

  • Blood safety index maintained consistently above target
  • 100% SANAS Accreditation maintained

Contribution to Long-term Sustainable Value

Related Material
Matters

  • Regulatory landscape
  • Future changing world
  • Financial and organisational sustainability

Reflecting on our performance against the 2021/2022 Scorecard and how we added value

Target achieved/exceeded New initiative on track against current plan (no concerns Improvements YOY No Concerns yet Below Target

Reflecting on our performance against the 2021/2022 Scorecard and how we added value

Target achieved/exceeded New initiative on track against current plan (no concerns Improvements YOY No Concerns yet Below Target

Below, we further unpack the various components of our performance against our iHEALTh strategy

Key Measured Initiatives

Below, we further unpack the various components of our performance against our iHEALTh strategy

Key Measured Initiatives

Blood safety index

  • >=95%

  • 97.3%

  • 97.24%

  • >=95%

Blood safety index

  • >=95%

  • 97.3%

  • 97.24%

  • >=95%

Accreditation

  • 100% SANAS Accreditation

  • 100%

  • 100%

  • 100% SANAS Accreditation

Accreditation

  • 100% SANAS Accreditation

  • 100%

  • 100%

  • 100% SANAS Accreditation

Meet ISO 9001 standards

  • New project

  • Baseline audits conducted for support areas and gap analysis completed

  • Fully compliant with ISO 9001 standards

Meet ISO 9001 standards

  • New project

  • Baseline audits conducted for support areas and gap analysis completed

  • Fully compliant with ISO 9001 standards

Meet SLA TAT for standard crossmatches

  • >90% of standard crossmatches completed within agreed SLA TAT of 120 minutes

  • 81.83% of standard crossmatches completed within agreed SLA TAT of 120 minutes
  • The TAT for standard crossmatches is improving, primarily as a result of improved reporting

  • 83.2%
  • Staff shortages during Covid-19 Cutbacks cause delays Instrument breakdowns Instrument suppliers changed Some manual testing required which increased TAT

  • >=90% of standard crossmatches completed within agreed SLA TAT of 120 minutes
  • Process improvements being considered
  • Moved to Testing and Quality on scorecard
  • Time and motion studies
  • Monitoring blood banks

Meet SLA TAT for standard crossmatches

  • >90% of standard crossmatches completed within agreed SLA TAT of 120 minutes

  • 81.83% of standard crossmatches completed within agreed SLA TAT of 120 minutes
  • The TAT for standard crossmatches is improving, primarily as a result of improved reporting

  • 83.2%
  • Staff shortages during Covid-19 Cutbacks cause delays Instrument breakdowns Instrument suppliers changed Some manual testing required which increased TAT

  • >=90% of standard crossmatches completed within agreed SLA TAT of 120 minutes
  • Process improvements being considered
  • Moved to Testing and Quality on scorecard
  • Time and motion studies
  • Monitoring blood banks

Turn-around time for units to become available for use

  • 95%

  • 144%

  • 91.4%
  • BI reporting improved causing the value to drop

  • >=95%
  • Software and hardware upgrades planned to improve sending of results

Turn-around time for units to become available for use

  • 95%

  • 144%

  • 91.4%
  • BI reporting improved causing the value to drop

  • >=95%
  • Software and hardware upgrades planned to improve sending of results

NAVIGATE TO:

NAVIGATE TO:

How can we help you?

Let's Connect

Head Office

  • 1 Constantia Boulevard Constantia Kloof, Roodepoort, 1709
  • (011) 761-9000
  • customerservice@sanbs.org.za

Main Links

Ⓒ 2022 - All Rights Are Reserved. SANBS Integrated Report. Created by Joshero (Pty) Ltd.

Head Office

  • 1 Constantia Boulevard Constantia Kloof, Roodepoort, 1709
  • (011) 761-9000
  • customerservice@sanbs.org.za

Main Links

Ⓒ 2022 - All Rights Are Reserved. SANBS Integrated Report. Created by Joshero (Pty) Ltd.